MARCHI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 371
EU - Europa 341
AS - Asia 73
Totale 785
Nazione #
US - Stati Uniti d'America 371
PL - Polonia 108
IT - Italia 75
IE - Irlanda 55
SE - Svezia 50
HK - Hong Kong 36
RU - Federazione Russa 23
CN - Cina 13
JO - Giordania 10
GB - Regno Unito 9
DK - Danimarca 7
SG - Singapore 7
DE - Germania 4
VN - Vietnam 4
ES - Italia 3
UA - Ucraina 3
CH - Svizzera 2
BY - Bielorussia 1
IN - India 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
Totale 785
Città #
Warsaw 108
Chandler 58
Dublin 55
Fairfield 52
Ashburn 36
Hong Kong 24
Moscow 23
Lawrence 18
Altamura 17
Woodbridge 17
Florence 15
Seattle 15
Wilmington 15
New York 14
Cambridge 13
Houston 13
Princeton 11
Ann Arbor 9
Buffalo 9
Medford 8
Alghero 7
Beijing 7
Boston 7
Copenhagen 7
Prato 7
Singapore 6
Boardman 5
Kent 5
Naples 5
Shanghai 5
Dong Ket 4
Bilbao 3
San Diego 3
Bagno a Ripoli 2
Bern 2
Bologna 2
Falls Church 2
Kilburn 2
Lecce 2
Lodi 2
London 2
Amsterdam 1
Andover 1
Anguillara Sabazia 1
Arezzo 1
Chennai 1
Clifton 1
Hillsboro 1
Norwalk 1
Phoenix 1
Rome 1
San Miniato Basso 1
Sapporo 1
Seoul 1
Southwark 1
Staranzano 1
Tavarnuzze 1
Viterbo 1
Wandsworth 1
Washington 1
Wuhan 1
Totale 637
Nome #
Muscle shortening maneuver and not topical anti-inflammatory therapy is effective in reducing the width of subacromial-subdeltoid bursa in shoulder impingement syndrome 171
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 107
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 73
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 67
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 51
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 50
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 50
Antiarrhythmic efficacy of anakinra in a young patient with autoimmune lymphocytic myocarditis 47
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 46
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 40
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care 24
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 18
Stage-specific therapy for hypertrophic cardiomyopathy 14
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 13
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 13
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 11
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 8
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 3
Totale 806
Categoria #
all - tutte 3.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 4 2
2019/2020109 2 10 2 4 8 13 14 16 13 9 13 5
2020/2021146 8 12 0 31 16 9 7 7 24 10 13 9
2021/202291 5 0 1 4 2 14 0 3 9 8 16 29
2022/2023270 19 64 19 10 17 42 39 14 29 7 3 7
2023/2024176 8 11 20 10 21 24 15 35 4 19 9 0
Totale 806